The study was supported by a company that has combined the two drugs in ... mean weight loss was significantly greater in the high- and low-dose bupropion/naltrexone groups than in the placebo ...

Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Obesity is a chronic medical condition that affects millions of people worldwide. And while BMI (body mass index) is not the be-all and end-all assessment of obesity (it's not without its problems ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

Currax Pharmaceuticals is taking a page out of Lesley Gore’s playbook to remind patients that obesity doesn’t own them. The drugmaker launched a campaign supporting its weight loss medication ...

The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

Encouraged by her weight-loss progress, Breen decided to give another member of this class of drugs, known as GLP-1 agonists, a shot. Eight months after he stopped taking naltrexone, in April 2023 ...